Antibodies as biomarkers for cancer risk: a systematic review. (2022)

First Author: Monroy-Iglesias MJ
Attributed to:  Preclinical efficacy of an antibody of the IgE class against a melanoma-associated antigen funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/cei/uxac030

PubMed Identifier: 35380164

Publication URI: http://europepmc.org/abstract/MED/35380164

Type: Journal Article/Review

Volume: 209

Parent Publication: Clinical and experimental immunology

Issue: 1

ISSN: 0009-9104